Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | LPL | P06858 | 1/20 | 0.43 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.43 |
| ▸ | ACACB | O00763 | 2/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ACACA | Q13085 | 1/20 | 0.40 |
| ▸ | PDE2A | O00408 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | PLK1 | P53350 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4796978 | 1.00 | ADRB2 (0.48) | ADRB2CA2LPLLIPGACACB | |
| Hydrochloric Acid SCHEMBL14121927 | 0.98 | ADRB2 (0.46) | ADRB2CA2LPLLIPGACACB | |
| SCHEMBL29342569 | 0.87 | HTR2A (0.50) | ADRB2CA2HTR2AKDM4EALDH1A1 | |
| SCHEMBL11686889 | 0.87 | HTR2A (0.50) | ADRB2CA2HTR2AKDM4EALDH1A1 | |
| SCHEMBL29342921 | 0.87 | HTR2A (0.50) | ADRB2CA2HTR2AKDM4EALDH1A1 | |
| SCHEMBL19174795 | 0.85 | HTR2A (0.57) | CA2LPLLIPGHTR2AKDM4E | |
| SCHEMBL15936164 | 0.84 | CA2 (0.47) | CA2LPLLIPGACACBHTR2A | |
| SCHEMBL19198643 | 0.84 | CA2 (0.47) | CA2LPLLIPGACACBHTR2A | |
| SCHEMBL1009348 | 0.84 | HTR2A (0.60) | LPLLIPGHTR2AKDM4EALDH1A1 | |
| SCHEMBL9945668 | 0.84 | HTR2A (0.60) | LPLLIPGHTR2AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10030033-B2 | Synthesis of an antiviral compound | GILEAD SCIENCES, INC. (US) | 2018-07-24 | — | — | US | disclosed |
| EP-0915080-B1 | Process for preparing optically active amines and optically active carboxylic acids, and intermediates for preparation | YAMAKAWA CHEMICAL IND (JP) | 2003-03-26 | — | — | EP | disclosed |
| US-6342636-B1 | REACTION OF ARYLALKYLAMINE WITH NAPHTHYLGLYCOLIC ACID AND DECOMPOSITION A DIASTEROMER SALT TO OBTAIN AN ENANTIOMORPH | YAMAKAWA CHEMICAL INDUSTRY CO., LTD. (JP) | 2002-01-29 | — | — | US | disclosed |
| EP-0915080-A1 | Process for preparing optically active amines and optically active carboxylic acids, and intermediates for preparation | YAMAKAWA CHEMICAL INDUSTRY CO., LTD. (JP) | 1999-05-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10030033-B2 | Synthesis of an antiviral compound | EIF2AK2, MAVS, SARS1 | ADRB2 4726/4885CA2 4738/4885LPL 4137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.